Refractory Classical Hodgkin Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab1Recruiting1
DB02546Vorinostat1Recruiting1